1-13 of 13
Rolf Ljung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Design of an Observational Study (PROVE) to Assess the Long-Term Effects of Prophylaxis with Simoctocog Alfa or Emicizumab on Joint and Bone Health in Hemophilia a Patients

Free
Robert Klamroth, Robert F Sidonio, Jr., Yesim Dargaud, Víctor Jiménez-Yuste, Rolf Ljung, Guy Young, Pratima Chowdary
Journal: Blood
Blood (2023) 142 (Supplement 1): 1255.
https://doi.org/10.1182/blood-2023-181725
Published: 2023
Journal Articles

Trial in Progress: An Open-Label, Multi-Center, First in Human, Phase 1/2a Trial to Evaluate the Safety and Preliminary Efficacy of Autologous Tolerogenic Dendritic Cells Ex Vivo Loaded with Recombinant Factor VIII (FVIII) in Adults with Congenital Hemophilia a (HA) with Neutralizing Antibodies to FVIII and Having Failed Immune Tolerance Induction (ITI)

Free
Jan Astermark, Rolf Ljung, Eva Karlsson, Hanjing Xie
Journal: Blood
Blood (2022) 140 (Supplement 1): 12733–12734.
https://doi.org/10.1182/blood-2022-157250
Published: 2022
Journal Articles

Predicting Thrombosis Recurrence in Children: The Role of Thrombophilia Testing

Free
Bader Allahyani, MD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-133384
Published: 2020
Journal Articles

Pulmonary Embolism in Children with Asymptomatic Proximal Deep Vein Thromboembolism: Single-Center Experience from Sweden

Free
Bader Allahyani, MD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-133289
Published: 2020
Journal Articles

Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

Free
Clinical Trials & Observations
H. Marijke van den Berg, Kathelijn Fischer, Manuel Carcao, Hervé Chambost, Gili Kenet, Karin Kurnik, Chris Königs, Christoph Male, Elena Santagostino, Rolf Ljung
Journal: Blood
Blood (2019) 134 (3): 317–320.
https://doi.org/10.1182/blood.2019000658
Published: 2019
Includes: Supplemental data
Journal Articles

Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B

Free
Yasmina L. Abajas, MD, Paul Edward Monahan, MD, Brenda Nielsen, RN, Pia Petrini, MD, Susanna Ranta, MD PhD, Geoffrey A. Allen, MD, Silvia Horneff, MD, Annika Martensson, MD PhD, Johannes Oldenburg, MD PhD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 1193.
https://doi.org/10.1182/blood-2018-99-120141
Published: 2018
Journal Articles

Venous Thromboembolism in Children 0-18 Years — a Regional Population-Based Study from Sweden

Free
Bader Allahyani, MD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 3805.
https://doi.org/10.1182/blood-2018-99-113844
Published: 2018
Journal Articles

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Free
Marijke Van den Berg, MD PhD, Kathelijn Fischer, Elena Santagostino, Herve Chambost, Karin Kurnik, Gili Kenet, MD, Christoph Male, MD, Anne Rafowicz, Helen Platokouki, Susanna Ranta, MD PhD, Christel Van Geet, MD, Johannes Oldenburg, Ri Liesner, Segolene Claeyssens, MD, Nadine Gretenkort-Andersson, Anne Mäkipernaa, PhD, Torben Stamm Mikkelsen, Manuel Carcao, Beatrice Nolan, Liz Chalmers, A.R. Cid, Teresa Álvarez-Roman, Carmen Altisent, Georges Rivard, MD FRCPC, Claudio Molinari, Martina Buehrlen, Rainer Kobelt, Carmen Escuriola, Manuela Carvalho, Christoph Koenigs, MD PhD, Mike Williams, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 2472.
https://doi.org/10.1182/blood-2018-99-114518
Published: 2018
Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Free
Maria Elisa Mancuso, MD PhD, Kathelijn Fischer, MD PhD MSc, Elena Santagostino, MD PhD, Johannes Oldenburg, Prof, Helen Platokouki, MD, Christoph Königs, MD PhD, Carmen Escuriola, MD, Georges-Etienne Rivard, MD, Ana Cid, MD, Manuel Carcao, MD, Rolf Ljung, MD PhD, Pia Petrini, MD, Anne Rafowicz, MD, Carmen Altisent, MD, Gili Kenet, MD, Raina Liesner, Karin Kurnik, MD, Christel Van Geet, MD PhD, Teresa Alvarez-Roman, MD, Tin Tin Yee, MD, Guenter Auerswald, Sr., MD, Rosario Perez-Garrido, MD, Beatrice Nolan, Hervé Chambost, Anne Makipernaa, MD, Angelo Claudio Molinari, MD, Angela Thomas, MBBS, PhD, Elizabeth Chalmers, MD, Mike Williams, MD, Rainer Kobelt, MD, Marijke Van den Berg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3774.
https://doi.org/10.1182/blood.V128.22.3774.3774
Published: 2016
Journal Articles

Can a “center effect” explain the higher frequency of inhibitors for a second-generation recombinant factor VIII product?

Free
H. Marijke van den Berg, Rolf Ljung
Journal: Blood
Blood (2015) 126 (18): 2164–2165.
https://doi.org/10.1182/blood-2015-08-663583
Published: 2015
Includes: Supplemental data
Journal Articles

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

Free
Clinical Trials & Observations
Kathelijn Fischer, Katarina Steen Carlsson, Pia Petrini, Margareta Holmström, Rolf Ljung, H. Marijke van den Berg, Erik Berntorp
Journal: Blood
Blood (2013) 122 (7): 1129–1136.
https://doi.org/10.1182/blood-2012-12-470898
Published: 2013
Includes: Supplemental data
Journal Articles

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Free
Clinical Trials & Observations
Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer, Günter Auerswald, Manuel Carcao, Elizabeth Chalmers, Hervé Chambost, Karin Kurnik, Ri Liesner, Pia Petrini, Helen Platokouki, Carmen Altisent, Johannes Oldenburg, Beatrice Nolan, Rosario Pérez Garrido, M. Elisa Mancuso, Anne Rafowicz, Mike Williams, Niels Clausen, Rutger A. Middelburg, Rolf Ljung, Johanna G. van der Bom
Journal: Blood
Blood (2013) 121 (20): 4046–4055.
https://doi.org/10.1182/blood-2012-09-457036
Published: 2013
Includes: Supplemental data
Journal Articles

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

Free
Manuel D. Carcao, H. Marijke van den Berg, Rolf Ljung, Maria Elisa Mancuso, C Altisent, G Auerswald, E Chalmers, H Chambost, A Cid, S Claeyssens, N Clausen, K Fischer, Van Creveld Kliniek, Ch van Geet, K Peerlinck, R Kobelt, W Kreuz, C Escuriola, K Kurnik, R Liesner, R Ljung, A Mäkipernaa, A Molinari, W Muntean, J Oldenburg, R Pérez Garrido, P Petrini, H Platokouki, A Rafowicz, E Santagostino, ME Mancuso, A Thomas, M Williams, SC Gouw, HM van den Berg, G Kenet, M Carcao, G Rivard
Journal: Blood
Blood (2013) 121 (19): 3946–3952.
https://doi.org/10.1182/blood-2012-11-469403
Published: 2013
Includes: Supplemental data